I wonder if there's any backwash from the swineflu epidemic washing through to TIS. Their VitroGro technology is also billed as "cell culture" and the next big thing for vaccine production is - "cell culture". Presently all infuenza vaccines are prepared using eggs - it's been this way for many years and is far from fool proof. And today on the BTA thread there's a news item about very low yields of swineflu vaccine being experienced from this egg based production technique.
That all begs the question of just who might be interested in a cell culture alternative to traditional egg methods. Maybe CSL. Makes me wonder if they've got any money?
I'm not an analyst - dyor
- Forums
- ASX - By Stock
- TIS
- mmmmmmmmmm
mmmmmmmmmm, page-4
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TIS (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online